BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32821481)

  • 1. Assessment of Choroidal Neovascularization Perfusion: A Pilot Study With Laser Speckle Flowgraphy.
    Calzetti G; Mora P; Favilla S; Ottonelli G; Devincenzi G; Carta A; Tedesco S; Mursch-Edlmayr A; Garhöfer G; Gandolfi S; Schmetterer L
    Transl Vis Sci Technol; 2020 Apr; 9(5):9. PubMed ID: 32821481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect on the ocular circulation induced by unilateral intravitreal injection of aflibercept in age-related maculopathy.
    Mursch-Edlmayr AS; Luft N; Podkowinski D; Ring M; Schmetterer L; Bolz M
    Acta Ophthalmol; 2019 Sep; 97(6):e927-e932. PubMed ID: 30916896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography angiography of types 1 and 2 choroidal neovascularization in age-related macular degeneration during anti-VEGF therapy: evaluation of a new quantitative method.
    Faatz H; Farecki ML; Rothaus K; Gunnemann F; Gutfleisch M; Lommatzsch A; Pauleikhoff D
    Eye (Lond); 2019 Sep; 33(9):1466-1471. PubMed ID: 30971814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
    Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
    Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An efficacy analysis of anti-vascular endothelial growth factor therapy for choroidal neovascularization secondary to multifocal choroiditis and comparison with wet age-related macular degeneration.
    Feng L; Hu JH; Chen J; Xie X
    J Zhejiang Univ Sci B; 2018 Apr.; 19(4):327-332. PubMed ID: 29616508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Changes in Submacular Choroidal Thickness after Intravitreal Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 14-Mo Follow-Up.
    Inan S; Baysal Z; Inan UU
    Curr Eye Res; 2019 Aug; 44(8):908-915. PubMed ID: 30909756
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Progression of Type 1 Neovascularization in Age-related Macular Degeneration Using Optical Coherence Tomography Angiography.
    Xu D; Dávila JP; Rahimi M; Rebhun CB; Alibhai AY; Waheed NK; Sarraf D
    Am J Ophthalmol; 2018 Mar; 187():10-20. PubMed ID: 29269100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short-term effects of aflibercept on the size of choroidal neovascularization lesion in treatment-resistant neovascular age-related macular degeneration as determined by spectral-domain optical coherence tomography.
    Abri Aghdam K; Seidensticker F; Pielen A; Framme C; Junker B
    Lasers Surg Med; 2016 Sep; 48(7):668-77. PubMed ID: 27111455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy.
    Rush RB; Rush SW; Aragon AV; Ysasaga JE
    Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration.
    Stem MS; Moinuddin O; Kline N; Thanos A; Rao P; Williams GA; Hassan TS
    JAMA Ophthalmol; 2018 Jul; 136(7):820-823. PubMed ID: 29800991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topographic Correspondence of Macular Atrophy With Choroidal Neovascularization in Ranibizumab-treated Eyes of the TREX-AMD Trial.
    Abdelfattah NS; Hariri AH; Al-Sheikh M; Pitetta S; Ebraheem A; Wykoff CC; Sadda SR;
    Am J Ophthalmol; 2018 Aug; 192():84-90. PubMed ID: 29763612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of three intravitreal injections of aflibercept on the ocular circulation in eyes with age-related maculopathy.
    Mursch-Edlmayr AS; Luft N; Podkowinski D; Ring M; Schmetterer L; Bolz M
    Br J Ophthalmol; 2020 Jan; 104(1):53-57. PubMed ID: 30979731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Hypoxia-Inducible Factor-1α and Vascular Endothelial Growth Factor by Chrysin in a Rat Model of Choroidal Neovascularization.
    Song JH; Moon KY; Lee SC; Kim SS
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of choroidal neovascularization in indocyanine green angiography after intravitreal ranibizumab injection.
    Lee JE; Kim HW; Lee SJ; Lee JE
    Retina; 2015 May; 35(5):999-1006. PubMed ID: 25590857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS; Ng WY; Ng SR; Tan SP; Yeo IY; Mathur R; Chan CM; Tan AC; Tan GS; Wong TY; Cheung CM
    Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK
    Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Optical Coherence Tomography Angiography-based Follow-up Observation of Wet Age-related Macular Degeneration after Intravitreal Anti-Ranibizumab Therapy].
    Yuan MZ; Zhou HY; Chen YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Jun; 41(3):359-366. PubMed ID: 31282330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.